Life Technologies Corporation sequence-based system for HLA typing

Thursday, 21 February, 2013 | Supplied by: Life Technologies


Life Technologies Corporation has received US Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. The Applied Biosystems 3500 Dx/3500xL Dx CS2 Genetic Analyzers, Invitrogen SeCore HLA Sequencing Kits and uTYPE Dx HLA Sequence Analysis Software constitute the first 510(k)-cleared, sequence-based system for HLA typing in the United States.

Tissue typing is an essential component of determining compatibility between donors and patients for organ and bone marrow transplantation. HLA typing on the 3500 Dx offers labs an optimised, streamlined workflow said to have higher resolution than other molecular HLA typing technologies such as sequence-specific oligonucleotide (SSO) methods.

Online: www.invitrogen.com
Phone: 1800 331 627
Related Products

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...

Azure Biosystems Ao Microplate Reader

The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...

Navinci Naveni Plex isPLA multiplex solution

The isPLA multiplex solution is designed to simultaneously detect PD1/PD-L1 interactions...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd